Novavax's stock soars after DoD contract to make its COVID-19 vaccine candidateMarket Watch • 06/05/20
Novavax Selects AGC Biologics to Manufacture Matrix-M™ Adjuvant for Novel COVID-19 VaccinePRNewsWire • 06/03/20
Novavax Makes a $167 Million Purchase to Boost Its Coronavirus Vaccine Production CapacityThe Motley Fool • 05/27/20
Front-line coronavirus workers could be vaccinated as soon as this year, Novavax CEO saysCNBC • 05/26/20
Novavax Begins Early Stage Clinical Study of Its Coronavirus Vaccine CandidateThe Motley Fool • 05/26/20
Novavax begins 1st phase human trials of its experimental Coronavirus vaccine in AustraliaInvezz • 05/26/20